20.6 C
New York
Wednesday, May 25, 2022

Greenrise Global Medical Hemp announces the launch of Dronabinol on the German market

- Advertisement -


Berlin and ERFURT, GermanyAnd November 17, 2021 / CNW / – Greenrise Global Brands Inc. (Formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), a wholly owned subsidiary, AMP Alternative Medical Products GmbH (“AMP”), a supplier of medical cannabis products to German pharmacies , announced the launch of a new medical cannabis product dronabinol available in pharmacies starting from January 2022.

Greenrise Global Logo (CNW Group / Greenrise Global Brands Inc.)

Dronabinol is pure tetrahydrocannabinol (THC) and registered as an active pharmaceutical ingredient (API).

Dronabinol AMP is “Made in Germany. “It will be offered at a competitive price and complement the AMP family of products that support any treatment that requires medicinal cannabis products for a growing range of treatment modalities being prescribed by an increasing number of physicians.

Dronabinol has been a prominent medicinal cannabis product in the world Germany For many years, it was often prescribed by doctors for pain control. Compared to the procedure of preparing vaporized forms of medicinal cannabis, many patients find it easier to take prescription dronabinol. Doctors believe the THC concentration of dronabinol is more accurate than that of flowers or extracts, making dose monitoring easier. Pharmacists use Dronabinol to fill prescriptions for medications that a doctor prescribes to patients, usually in the form of drops or solutions.

Dronabinol is Germany The medicinal cannabis product is often prescribed, which accounts for 35% of all cannabis prescriptions and €46.5 million in sales in 2020. In Germany, the total sales of medical cannabis from repaid prescriptions amounted to 165 million euros, which represents about 90% of the medical cannabis market in 2020.

AMP’s national sales team is currently receiving training with medical professionals to learn about the benefits of dronabinol for physician patients and methods for preparing pharmacists’ prescriptions.

AMP has selected a German partner as the supplier of dronabinol. Doctors and pharmacists can find more information about the product or order on the AMP website: https://amp-eu.com/doccheck-login

Dr. said. Stefan FeuersteinMD, AMP, President and CEO of Greenrise Global. AMP’s Dronabinol delivers the best quality for patients and the best value for pharmacists and insurance companies compared to the limited number of other products currently on the market.”

About Greenrise Global Brands Inc.

Greenrise Global helps people realize the beneficial properties of cannabis. Greenrise Global is a Canadian company listed on the stock exchange with two German subsidiaries: Greenrise GmbH (“Greenrise Wellbeing”) and AMP Alternative Medical Products GmbH (“AMP”). Greenrise Wellbeing is a CBD health company based in Hamburg, with brands including herbs And Canavix® in her wallet. AMP is based in Erfurt and supplies medical cannabis products to pharmacies Germany, including medical cannabis brands from AfricaAnd BerokanAnd Little Green Pharma And AMP’s Line of branded products and sold through nationwide sales team. AMP complies with the German Drug Act (BtMG) and the regulatory requirements of the Free State of Thuringia, ensuring that products imported from around the world are sold in Germany Meets European Union Good Manufacturing Practices (EU-GMP) standards.

For more information about Greenrise Global, please visit www.greenriseglobal.com

Neither the CSE nor the Regulatory Services Provider (as this term is defined in the CSE Policies) is responsible for the adequacy or accuracy of this version.

This press release contains forward-looking statements that are based on the Company’s expectations, estimates and expectations regarding its business and the economic environment in which it operates, including with respect to its business plans, milestones and timing. Although the Company believes that the expectations expressed in such forward-looking statements are based on reasonable assumptions, these statements do not guarantee future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual results and outcomes may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to publicly update them to reflect new information or the occurrence of future events or conditions unless otherwise required by law.

Source: Greenrise Global Brands Inc.

Cision

Cision

View original content for multimedia download: http://www.newswire.ca/en/releases/archive/November2021/17/c2637.html

Grow guide for marijuana beginners.
- Advertisement -THC University

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Connected

420FansLike
2,320FollowersFollow
420SubscribersSubscribe
- Advertisement -

Latest Articles